Fig. 3From: Predicted impact of lipid lowering therapy on cardiovascular and economic outcomes of Swedish atherosclerotic cardiovascular disease guidelinePredicted direct cardiovascular events costs avoided by percent LDL-C reduction in base-, and calibrated casesBack to article page